Odyssey Therapeutics, Inc. (ODTX) Discusses Additional Phase IIa Data for OD-001 in Ulcerative Colitis from UEG Week Presentation Transcript

SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The reports are tied to Global. The first report grouped here was at 20 Oct 2026, 19:14 UTC. The headline in use is “Odyssey Therapeutics, Inc. (ODTX) Discusses Additional Phase IIa Data for OD-001 in Ulcerative Colitis from UEG Week Presentation Transcript”. This note is SignalsMonitor's own briefing, not the publisher's article.